Please use this identifier to cite or link to this item:
Title: Year in review 2015: Interstitial lung disease, pulmonary vascular disease, pulmonary function, sleep and ventilation, cystic fibrosis and paediatric lung disease
Authors: Piper, A.
Corte, T. J.
Wainwright, C.
Wort, S. J.
Eves, N. D.
Jo, H. E.
Issue Date: 2016
Source: 21, (3), 2016, p. 556-566
Pages: 556-566
Journal: Respirology
Abstract: L6087462562016-03-08
DOI: 10.1111/resp.12749
Resources: |
Keywords: histopathology;human;interstitial lung disease;Loeffler pneumonia;lung biopsy;lung clearance;lung function;lung injury;mental health;microbiology;patient compliance;pediatrics;phase 3 clinical trial (topic);portopulmonary hypertension;positive end expiratory pressure ventilation;priority journal;pulmonary arteriovenous fistula;pulmonary hypertension;pulmonary vascular disease;respiratory tract inflammation;review;single nucleotide polymorphism;sleep;sleep disordered breathing;acetylcysteinebiological marker;corticosteroid;cystic fibrosis transmembrane conductance regulator;ivacaftor;lumacaftor;nintedanib;pirfenidone;artificial ventilation;bacterial infection;cystic fibrosis;disease association;drug response;fibrosing alveolitis;forced expiratory volume;functional assessment;gene therapy;genetic analysis;genotype
Type: Article
Appears in Sites:Children's Health Queensland Publications

Show full item record

Page view(s)

checked on Dec 5, 2022

Google ScholarTM



Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.